Gray/White Matter Contrast in Parkinson’s Disease

Gray/white matter contrast (GWC) decreases with aging and has been found to be a useful MRI biomarker in Alzheimer’s disease (AD), but its utility in Parkinson’s disease (PD) patients has not been investigated. The aims of the study were to test whether GWC is sensitive to aging changes in PD patien...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Aging Neurosci
Main Authors: Uribe, Carme, Segura, Barbara, Baggio, Hugo C., Abos, Alexandra, Garcia-Diaz, Anna I., Campabadal, Anna, Marti, Maria J., Valldeoriola, Francesc, Compta, Yaroslau, Bargallo, Nuria, Junque, Carme
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2018
Assuntos:
Neuroscience
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5881246/
https://ncbi.nlm.nih.gov/pubmed/29636679
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fnagi.2018.00089
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados